Levodopa: Rational and irrational pharmacology

[1]  T. Chase,et al.  Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms , 1994, Annals of neurology.

[2]  J. Bennett,et al.  Suppression of dyskinesias in advanced Parkinson's disease , 1993, Neurology.

[3]  T. Chase,et al.  Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's disease , 1992, Annals of neurology.

[4]  J. Nutt,et al.  Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon. , 1992, Archives of neurology.

[5]  J. Obeso,et al.  Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients. , 1991, Brain : a journal of neurology.

[6]  I. Heuser,et al.  Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease , 1990, Annals of neurology.

[7]  A. Lees,et al.  Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[8]  A J Lees,et al.  Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Bartko,et al.  Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II , 1988, Annals of neurology.

[10]  J. Nutt,et al.  Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuations , 1988, Neurology.

[11]  M. Muenter,et al.  L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. , 1971, Mayo Clinic proceedings.

[12]  George C. Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.